Vitamin D deficiency and the COVID-19 pandemic
Patrick Zemb, Peter Bergman, Carlos A. Camargo, Etienne Cavalier, Catherine Cormier, Marie Courbebaisse, Bruce W. Hollis, Fabrice Joulia, Salvatore Minisola, Stefan Pilz, Paweł Płudowski, François Schmitt, Mihnea Zdrenghea, Jean-Claude Souberbielle
Abstract
• Vitamin D deficiency is very common. • Randomised controlled trials showed that vitamin D decreases acute respiratory infections (ARIs). • Vitamin D deficiency is an easily modifiable factor of ARIs. • Daily vitamin D supplementation with moderate doses is safe and cheap. • Even a small decrease in COVID-19 infections would easily justify this intervention.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)vitamin D deficiencyMedicinePandemicVitamin D and neurologyVitamin2019-20 coronavirus outbreakRandomized controlled trialSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineVirologyOutbreakDiseaseInfectious disease (medical specialty)Vitamin D Research StudiesVitamin C and Antioxidants ResearchClimate Change and Health Impacts